|
| 37473998 | Lobectomy, segmentectomy, or wedge resection for peripheral clinical T1aN0 non-small cell lung cancer: A post hoc analysis of CALGB 140503 (Alliance). | J Thorac Cardiovasc Surg | 2024 |
| 37597739 | Cancer and Leukemia Group B 140503: Is it time to turn the page on Lung Cancer Study Group 821? | J Thorac Cardiovasc Surg | 2024 |
| 37052430 | Volume outcome relationship in postesophagectomy leak: a systematic review and meta-analysis. | Int J Surg | 2024 |
| 34475320 | Extended Lymphadenectomy Improves Survival After Induction Chemoradiation for Esophageal Cancer: A Propensity-Matched Analysis of the National Cancer Database. | Ann Surg | 2023 |
| 37759102 | TIMP1 is an early biomarker for detection and prognosis of lung cancer. | Clin Transl Med | 2023 |
| 37790365 | Deficiency of metabolic regulator PKM2 activates the pentose phosphate pathway and generates TCF1+ progenitor CD8+ T cells to improve checkpoint blockade. | Res Sq | 2023 |
| 37934099 | A 20-year Follow-up of the International Early Lung Cancer Action Program (I-ELCAP). | Radiology | 2023 |
| 37926198 | Should sampling of three N2 stations be a quality metric for curative resection of stage I lung cancer? | J Thorac Cardiovasc Surg | 2023 |
| 37290119 | Regulation of PD-L1 Trafficking from Synthesis to Degradation. | Cancer Immunol Res | 2023 |
| 37085570 | Improving outcomes in patients with oesophageal cancer. | Nat Rev Clin Oncol | 2023 |
| 37046063 | Surgical Treatment at an Academic Medical Center is Associated with Statistically Insignificant Lung Cancer Survival Outcome Differences Related to ZIP Code. | World J Surg | 2023 |
| 37467930 | Overall survival with adjuvant atezolizumab after chemotherapy in resected stage II-IIIA non-small-cell lung cancer (IMpower010): a randomised, multicentre, open-label, phase III trial. | Ann Oncol | 2023 |
| 37296877 | Sub-Lobar Resection: The New Standard of Care for Early-Stage Lung Cancer. | Cancers (Basel) | 2023 |
| 36624093 | Tumor-intrinsic IRE1α signaling controls protective immunity in lung cancer. | Nat Commun | 2023 |
| 36402582 | Commentary: Neoadjuvant immune checkpoint monotherapy for lung cancer: Has the train left the station? | J Thorac Cardiovasc Surg | 2023 |
| 36780674 | Lobar or Sublobar Resection for Peripheral Stage IA Non-Small-Cell Lung Cancer. | N Engl J Med | 2023 |
| 36915197 | Proximity proteome mapping reveals PD-L1-dependent pathways disrupted by anti-PD-L1 antibody specifically in EGFR-mutant lung cancer cells. | Cell Commun Signal | 2023 |
| 36841745 | Safety of adjuvant atezolizumab after pneumonectomy/bilobectomy in stage II-IIIA non-small cell lung cancer in the randomized phase III IMpower010 trial. | J Thorac Cardiovasc Surg | 2023 |
| 36796082 | A Unique Cellular Organization of Human Distal Airways and Its Disarray in Chronic Obstructive Pulmonary Disease. | Am J Respir Crit Care Med | 2023 |
| 36174774 | Integration of New Systemic Adjuvant Therapies for Non-small Cell Lung Cancer: Role of the Surgeon. | Ann Thorac Surg | 2023 |
| 35866662 | Ten-Year Survival and Recurrence Patterns After Three-Field Lymph Node Dissection for Squamous Cell and Adenocarcinoma of the Esophagus. | Ann Surg | 2023 |
| 36028357 | Surgical resection after neoadjuvant durvalumab and radiation is feasible and safe in non-small cell lung cancer: Results from a randomized trial. | J Thorac Cardiovasc Surg | 2023 |
| 35256160 | Adjuvant therapy for early-stage non-small cell lung cancer: The breaking of a new dawn. | J Thorac Cardiovasc Surg | 2023 |
| 34281703 | Sublobar resection is comparable to lobectomy for screen-detected lung cancer. | J Thorac Cardiovasc Surg | 2022 |
| 35459540 | Safety of lung cancer surgery during COVID-19 in a pandemic epicenter. | J Thorac Cardiovasc Surg | 2022 |
| 35385730 | Global evolution of the tumor microenvironment associated with progression from preinvasive invasive to invasive human lung adenocarcinoma. | Cell Rep | 2022 |
| 36049655 | A Knock-In Mouse Model of Thymoma With the GTF2I L424H Mutation. | J Thorac Oncol | 2022 |
| 33500130 | Commentary: Surgery for ground-glass nodules: Free lunch or slippery slope? | J Thorac Cardiovasc Surg | 2022 |
| 35041520 | Minimally Invasive Surgery for Lung Cancer Following Neoadjuvant Therapy in the United States. | J Laparoendosc Adv Surg Tech A | 2022 |
| 35122075 | Author Correction: Radiation-activated secretory proteins of Scgb1a1<sup>+</sup> club cells increase the efficacy of immune checkpoint blockade in lung cancer. | Nat Cancer | 2022 |
| 35181271 | Extent of Resection Influences Survival in Early-Stage Lung Cancer With Occult Nodal Disease. | Ann Thorac Surg | 2022 |
| 35332150 | Integrative network analysis of early-stage lung adenocarcinoma identifies aurora kinase inhibition as interceptor of invasion and progression. | Nat Commun | 2022 |
| 35294260 | Expression of the mono-ADP-ribosyltransferase ART1 by tumor cells mediates immune resistance in non-small cell lung cancer. | Sci Transl Med | 2022 |
| 34580031 | Lung Cancer Stage Shift as a Result of COVID-19 Lockdowns in New York City, a Brief Report. | Clin Lung Cancer | 2022 |
| 34454901 | Outcomes After Surgical Resection of Early-stage Lung Adenocarcinomas With Epidermal Growth Factor Receptor Mutations. | Ann Thorac Surg | 2022 |
| 34321179 | Two-field lymph node dissection or three-field lymph node dissection. What's in a name? | J Thorac Cardiovasc Surg | 2022 |
| 33008872 | Low Subcutaneous Adiposity and Mortality in Esophageal Cancer. | Cancer Epidemiol Biomarkers Prev | 2021 |
| 34917944 | Radiation-activated secretory proteins of <i>Scgb1a1</i><sup>+</sup> club cells increase the efficacy of immune checkpoint blockade in lung cancer. | Nat Cancer | 2021 |
| 34555333 | Adjuvant atezolizumab after adjuvant chemotherapy in resected stage IB-IIIA non-small-cell lung cancer (IMpower010): a randomised, multicentre, open-label, phase 3 trial. | Lancet | 2021 |
| 34015311 | Neoadjuvant durvalumab with or without stereotactic body radiotherapy in patients with early-stage non-small-cell lung cancer: a single-centre, randomised phase 2 trial. | Lancet Oncol | 2021 |
| 34119472 | CUL4<sup>high</sup> Lung Adenocarcinomas Are Dependent on the CUL4-p21 Ubiquitin Signaling for Proliferation and Survival. | Am J Pathol | 2021 |
| 34286887 | Validation of a Circulating Tumor DNA-Based Next-Generation Sequencing Assay in a Cohort of Patients with Solid tumors: A Proposed Solution for Decentralized Plasma Testing. | Oncologist | 2021 |
| 32711979 | Commentary: Can machine learning reduce readmissions after esophagectomy? A consummation devoutly to be wished. | J Thorac Cardiovasc Surg | 2021 |
| 32127206 | Commentary: Where is the leak? From the anastomosis or the database? | J Thorac Cardiovasc Surg | 2020 |
| 31704888 | Differential Contributions of Pre- and Post-EMT Tumor Cells in Breast Cancer Metastasis. | Cancer Res | 2020 |
| 32057814 | Staple Line Thickening After Sublobar Resection: Reaction or Recurrence? | Ann Thorac Surg | 2020 |
| 31668538 | Commentary: High-dose induction chemoradiation for lung cancer: The past is prologue. | J Thorac Cardiovasc Surg | 2020 |
| 32045555 | Lung Cancer Surveillance After Definitive Curative-Intent Therapy: ASCO Guideline Summary. | JCO Oncol Pract | 2020 |
| 31829901 | Lung Cancer Surveillance After Definitive Curative-Intent Therapy: ASCO Guideline. | J Clin Oncol | 2020 |
| 31765620 | Sternal Reconstruction Using Customized 3D-Printed Titanium Implants. | Ann Thorac Surg | 2020 |